Cefuroxime Injection, Powder, For Solution
Product Images NDC 0143-9569

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cefuroxime (NDC 0143-9569). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cefuroxime For Injection Pbp Novaplus 1)

FDA Label Image

Ndc 0143-9569-01 Rx Only Cefuroxime For Injection, Usp Pharmacy Bulk Package Not For Direct Infusion For Intravenous Use Only 7.5 G/vial Not To Be Dispensed As A Unit After Constitution Further Dilution Is Required Prior To Use. This Package Is Not Intended To Be Dispensed As A Unit. This Is A Pharmacy Bulk Package Which Contains Many Single Doses For Use In A Pharmacy Admixture Program. See Package Insert For Proper Use. Each Pharmacy Bulk Package Vial Contains Sterile Cefuroxime Sodium Equivalent To Cefuroxime 7.5 G. Cefuroxime For Injection Contains Approximately 54.2 mg (2.4 Meq) Of Sodium Per Gram Of Cefuroxime Activity. Usual Dosage: See Package Insert. Store At 20º To 25ºc (68º To 77ºf) [see Controlled Room Temperature]. Protect From Light. Constitution: Penetrate One Time Using A Sterile Dispensing Device. Add 77 mL Of Sterile Water For Injection. Shake Well To Dissolve. The Constituted Solution Occupies A Volume Of About 82.5 mL And Contains Approximately 750 mg Of Cefuroxime Per 8 mL. Not For Direct Infusion. Dispense Aliquots From The Vial Via A Suitable Dispensing Device Into Infusion Fluids Under A Laminar Flow Hood Using Aseptic Technique. Withdraw Contents Without Delay. Discard Vials 4 Hours After Initial Entry. Color Changes In Solution Do Not Affect Potency. Date And Time Of Entry:_______/________ (Cefuroxime For Injection Pbp Novaplus 2)

Cefuroxime is an injectable medication available in a Pharmacy Bulk Package for intravenous use only. Each vial contains 7.5 g of the medication and should not be dispensed as a unit. Prior to use, further dilution is required. The medication must be stored at a temperature of 25°C (77°F) and should be discarded if the contents are not used immediately after reconstitution. The provided information also contains instructions for reconstitution of the medication.*

FDA Label Image

Ndc 0143-9569-10 Rx Only Cefuroxime For Injection, Usp Pharmacy Bulk Package (NOT FOR DIRECT INFUSION FOR INTRAVENOUS USE ONLY 7.5 g/vial AFTER CONSTITUTION FURTHER DILUTION IS REQUIRED PRIOR TO USE THIS PACKAGE IS NOT INTENDED TO BE DISPENSED AS A UNIT PROTECT FROM LIGHT)

Cefuroxime is a medication that is injected and it requires further dilution before use. It comes in a package and the brand name is Novaplus.*

FDA Label Image

Ndc 0143-9569-10 Rx Only Cefuroxime For Injection, Usp Pharmacy Bulk Package (NOT FOR DIRECT INFUSION FOR INTRAVENOUS USE ONLY 7.5 g/vial AFTER CONSTITUTION FURTHER DILUTION IS REQUIRED PRIOR TO USE THIS PACKAGE IS NOT INTENDED TO BE DISPENSED AS A UNIT PROTECT FROM LIGHT)

This text appears to be a product label with information about the item's Global Trade Item Number (GTIN), Serial Number (SN), expiration date (EXP), and lot number (LOT). It does not provide any additional information about the product or its specifications.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.